Latest Articles
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - BioSpace
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids BioSpace
Published: May 7, 2025, 1:28 p.m.
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - The Manila Times
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids The Manila Times
Published: May 7, 2025, 12:24 p.m.
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - PR Newswire
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids PR Newswire
Published: May 7, 2025, noon
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - 스페셜타임스
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids 스페셜타임스
Published: May 7, 2025, noon
Molecular profiling can safely reduce radiation for women with endometrial cancer: Clinical trial results - Medical Xpress
Molecular profiling can safely reduce radiation for women with endometrial cancer: Clinical trial results Medical Xpress
Published: May 4, 2025, 9 p.m.
Biokin Pharmaceutical Obtains Approval for Cervical, Endometrial Cancer Clinical Trial - marketscreener.com
Biokin Pharmaceutical Obtains Approval for Cervical, Endometrial Cancer Clinical Trial marketscreener.com
Published: April 28, 2025, 9:23 a.m.
Clinical Trial Participation Gaps in Endometrial Cancer - Physician's Weekly
Clinical Trial Participation Gaps in Endometrial Cancer Physician's Weekly
Published: April 8, 2025, 1:53 p.m.
Endometrial Cancer Treatment Market 2034: Clinical Trials, - openPR.com
Endometrial Cancer Treatment Market 2034: Clinical Trials, openPR.com
Published: April 4, 2025, 4:30 a.m.
Chronic pelvic pain and botulinum toxin.
Botulinum toxin is being explored as a treatment for chronic pelvic pain, a major cause of suffering and disability in both women and men worldwide. For chronic pelvic pain in …
Published: March 26, 2025, midnight
Comparative pregnancy rate after colorectal resection versus other surgical procedures for deep infiltrating rectal endometriosis: a systematic review and meta-analysis.
The debate around colorectal surgery for endometriosis has been ongoing, but to date no meta-analysis has investigated the impact of the different surgical approaches on the pregnancy rate. The aim …
Published: March 18, 2025, midnight
Link copied to clipboard!